摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-phenoxyisonicotinic acid | 54629-99-1

中文名称
——
中文别名
——
英文名称
3-phenoxyisonicotinic acid
英文别名
3-Phenoxy-isonicotinsaeure;3-Phenoxypyridine-4-carboxylic acid
3-phenoxyisonicotinic acid化学式
CAS
54629-99-1
化学式
C12H9NO3
mdl
MFCD24160363
分子量
215.208
InChiKey
FDQFTGXHOIXOCY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    59.4
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-phenoxyisonicotinic acid 在 PPA 作用下, 反应 16.0h, 生成 5-(1-methyl-piperidin-4-yl)-5H-chromeno[2,3-c]pyridin-10-ol
    参考文献:
    名称:
    Benzopyranopyridine derivatives. 1. Aminoalkyl derivatives of the azaxanthenes as bronchodilating agents
    摘要:
    The preparation of the four isomeric azaxanthones 3 and a number of their aromatic ring substituted derivatives is described. These ketones were converted into the title compounds which were examined for their biological properties. The most interesting compound in this series, the 1-methyl-4-piperidylidene derivative of 1-azaxanthene, shows the profile of an orally effective potent bronchodilating agent as well as a moderate antihistamine. Biological properties of this compound were compared to a number of antihistamines as well as known bronchodilating agents. Structure-activity relationships are also discussed.
    DOI:
    10.1021/jm00235a001
  • 作为产物:
    描述:
    苯酚盐酸copper(l) iodidecaesium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 18.0h, 生成 3-phenoxyisonicotinic acid
    参考文献:
    名称:
    INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN
    摘要:
    描述了用于调节成纤维细胞活化蛋白(FAP)的化合物和组合物。这些化合物和组合物可能被用作治疗疾病的治疗剂,包括高增殖性疾病。
    公开号:
    US20190185451A1
点击查看最新优质反应信息

文献信息

  • Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
    申请人:Nilsson Peter
    公开号:US20120004244A1
    公开(公告)日:2012-01-05
    There is provided compounds of formula I, wherein E 1 , E 2a , E 2b , E 2c , E 4 , D 1 , D 2 , D 3 , L 1 , Y 1 , L 2 and Y 2 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C 4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
    提供了I式化合物,其中E1、E2a、E2b、E2c、E4、D1、D2、D3、L1、Y1、L2和Y2在说明中给出了含义,以及其药学上可接受的盐。这些化合物在治疗需要或希望抑制白三烯C4合酶的疾病,特别是呼吸道疾病和/或炎症的治疗中是有用的。
  • 3-Phenoxypyridine 1-oxides as anticonvulsant agents
    作者:Michael R. Pavia、Charles P. Taylor、Fred M. Hershenson、Sandra J. Lobbestael、Donald E. Butler
    DOI:10.1021/jm00399a027
    日期:1988.4
    The anticonvulsant activity of a series of 3-phenoxypyridine 1-oxides is described. An investigation carried out to optimize the activity/side effect ratio provided 4-methyl-3-phenoxypyridine 1-oxide, 3, as the derivative of choice. Overall, 3 has a pharmacological profile that is very similar to phenytoin. It exhibited significant anticonvulsant activity at doses that did not produce ataxia or sedation but caused increased spontaneous behavioral activity not seen with most anticonvulsants. The short duration of pharmacological effect of 3 was attributed to metabolic hydroxylation at the C-4 pyridine methyl group; however, structural modifications designed to inhibit this metabolic pathway were unsuccessful.
  • VILLANI F. J.; MANN T. A.; WEFER E. A.; HANNON J.; LARCA L. L.; LANDON M.+, J. MED. CHEM. <JMCM-AR>, 1975, 18, NO 1, 1-8
    作者:VILLANI F. J.、 MANN T. A.、 WEFER E. A.、 HANNON J.、 LARCA L. L.、 LANDON M.+
    DOI:——
    日期:——
  • PAVIA, MICHAEL R.;TAYLOR, CHARLES P.;HERSHENSON, FRED M.;LOBBESTAEL, SAND+, J. MED. CHEM., 31,(1988) N 4, 841-847
    作者:PAVIA, MICHAEL R.、TAYLOR, CHARLES P.、HERSHENSON, FRED M.、LOBBESTAEL, SAND+
    DOI:——
    日期:——
  • [EN] INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN<br/>[FR] INHIBITEURS DE LA PROTÉINE D'ACTIVATION DES FIBROBLASTES
    申请人:PRAXIS BIOTECH LLC
    公开号:WO2019118932A1
    公开(公告)日:2019-06-20
    Compounds and compositions for modulating fibroblast activation protein (FAP) are described. The compounds and compositions may find use as therapeutic agents for the treatment of diseases, including hyperproliferative diseases.
查看更多